About this Medicine article
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group by M. Feuring-Buske; M. Kneba; M. Unterhalt; A. Engert; M. Gramatzki; E. Hiller; L. Trümper; W. Brugger; H. Ostermann; J. Atzpodien; M. Hallek; E. Aulitzky; W. Hiddemann is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- M. Feuring-Buske; M. Kneba; M. Unterhalt; A. Engert; M. Gramatzki; E. Hiller; L. Trümper; W. Brugger; H. Ostermann; J. Atzpodien; M. Hallek; E. Aulitzky; W. Hiddemann
- Publisher
- Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0939-5555)
- Published
- 2000
- Language
- EN
- Field
- Medicine (Health Sciences)